(Q47578007)

4 February 2018

title

HIV epitope-peptides in aluminum adjuvant induced high levels of epitope-specific antibodies (English)

1 reference

4 February 2018

0 references

H Tian

1

1 reference

4 February 2018

Y Xiao

series ordinal

2

1 reference

4 February 2018

M Zhu

series ordinal

3

1 reference

4 February 2018

Y H Chen

series ordinal

4

1 reference

4 February 2018

publication date

1 April 2001

1 reference

4 February 2018

International Immunopharmacology

published in

1 reference

4 February 2018

volume

1

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

763-768

1 reference

4 February 2018

Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

HIV type 1 coreceptors, neutralization serotypes, and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Epitope vaccine: a new strategy against HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Characterization of immune suppression by a synthetic HIV gp41 peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

A common epitope on gp41, IFN-alpha and IFN-beta induces protective activity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Structure and polymorphism of HIV-1 third variable loops

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Immunogenicity of neutralizing epitopes on multiple-epitope vaccines against HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Induction of high levels of epitope-specific antibodies by epitope/peptide candidate vaccines against human immunodeficiency virus type-1 (HIV-1).

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Epitope-vaccine induces high levels of ELDKWA-epitope-specific neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

Viral persistence in vivo through selection of neutralizing antibody-escape variants.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900017-0

7 January 2021

10.1016/S1567-5769(01)00017-0

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018